Zimmer Biomet ( NYSE: ZBH) was upgraded at Roth Capital Partners to Buy from Neutral on the back of its recent acquisition of Monogram Technologies, a company specializing in robotics.

Zimmer Biomet inked a $177 million deal to purchase Monogram Technologies, developer of a hands-free robotic surgery system ...

Oakmark Funds, advised by Harris Associates, released its “Oakmark Equity and Income Fund” Q2 2025 investor letter. A copy of ...

New HHS contract reviews are delaying care and filling of vacancies, IHS insiders tell Stat News. Meanwhile, KFF Health News dives into rehabilitation hospitals.

The move is expected to bolster Zimmer’s ROSA Robotics platform with Monogram's semi-autonomous and fully autonomous robotic ...

Let’s take a look at how surgical equipment & consumables - diversified stocks fared in Q1, starting with BD (NYSE:BDX). The ...

Medical device company Zimmer Biomet has announced its acquisition of robotics firm Monogram Technologies for approximately ...

Zimmer Biomet it will acquire robotics firm Monogram Technologies for about $177 million, adding Monogram’s semi- and fully ...

The Monogram acquisition will contribute to revenue growth in 2027 by improving Zimmer Biomet's robotic knee adoption in the ...

The deal allows Zimmer to sell Getinge’s infection control and surgical products alongside its orthopedic implants and robots ...

Monogram develops semi- and fully autonomous robotic technologies. Zimmer Biomet expects its offerings to add new, ...

Shares of Monogram Technologies (NASDAQ:MGRM) jumped 60% following news that Zimmer Biomet (NYSE:ZBH) has agreed to acquire ...